LOX-1 levels were higher in OSA patients with diabetes than in OSA patients without diabetes (1527.12 ± 901.69 pg/mL vs. 1024.24 ± 530.66 pg/mL; p = 0.03) (Figure 1). The gene discussed is OLR1; the disease is obstructive sleep apnea syndrome.